CD Skripsi
Sintesis Pirazolin 5-(2-Bromofenil)-3-(1- Hidroksinaftalen-2-Il)-1- Fenil-4,5-Dihidro-1h- Pirazol Dan Studi In Silico Sebagai Agen Antikanker
Pyrazoline is five ring heterocyclic compounds with two adjacent nitrogen atoms which is known to have diverse biological activities such as antioxidant, antitumor and anticancer agent. Pyrazoline (5-(2-bromophenyl)-3-(1-hydroxynaphthalene-2- yl)-1-phenyl-4,5-dihydro-1H-pyrazole has successfully synthesized with several phases of reaction. The reaction begins formation of chalcone 3-(2-bromophenyl)- 1-(1-hydroxynaphthalene-2-yl)-2-propen-1-on by reacting 1-hydroxy-2-acetyl naphthalene compound with 2-bromobenzaldehide using microwave irradiation method. Chalcone synthesis through Claisen-Schmidt condensation reactions with yield 85 %. The next stepwas reacted chalcone with phenyl hydrazine to produce target compound used sodium hydroxide catalyst with a monowave for 3 hours at a temperature of 80℃ and the resulting yield was 81%. The purity of the target compound was determined using TLC, melting point and HPLC. Analysis and confirming its structure based on spectroscopic data of UV, FTIR, 1H-NMR, 13C-NMR and LCMS. Furthermore, the results of the synthesis of the PF-NH1-2Br compound were studied in silico using the molecular docking method by looking at the interaction between the target compound as a ligand for the estrogen receptor α (ERα) PDB ID: 3ERT. The interaction of the target compound with the estrogen receptor α shows a free binding value (∆Gbind) of -10.73 kcal/mol and an inhibition constant (Ki) value of 13.71 nM.
Tidak tersedia versi lain